MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

CUSIP: 61559X104

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+2,322,943
Put/Call ratio
104%
SEC-reported price per share
$60.39
Number of holders
124
Value change
+$147,969,282
Number of buys
84
Open additional details 1 more signal available
Number of sells
61
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
80,766,491

Security key

61559X104

Report period

Q4 2023

Institutions

124

Top holders

10

Ownership snapshot

Top reported holders of MLTX - MoonLake Immunotherapeutics - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F 3/4/5 Highest disclosed value: $1,239,823,188 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $1.24B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Disclosed position value Top 5
BVF INC/IL $1.24B
Cormorant Asset Management, LP $464.1M
FMR LLC $193.64M
Helix Holdings LLC $192.57M
PRICE T ROWE ASSOCIATES INC /MD/ $120.72M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
—
denominator unverified
$1,239,823,188
21,751,284 shares
— 30 Sep 2023
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$464,099,700
8,142,100 shares
— 30 Sep 2023
FMR LLC
13F
Company
13F
—
denominator unverified
$193,643,420
3,397,253 shares
— 30 Sep 2023
Helix Holdings LLC
3/4/5
Former 10% Holder
—
denominator unverified
$192,569,820
3,215,000 shares
— 05 Apr 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$120,719,000
2,117,868 shares
— 30 Sep 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$115,960,572
2,034,396 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
124
Shares
58,433,271
Rows available
124
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
118
Q4 2023 holders
124
Holder diff
6
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .